EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Spatially Resolved Metabolomic Profiling Reveals Progression-Associated Metabolic Reprogramming in Colorectal Liver Metastasis

Ying Zhu iD, Yixuan Cai iD, Qianyu Wang, Hanchuan Guo, Qianqian Xie, Yingshi Xiang, Songlin Yu, Bin Wu, Ling Qiu

Metabolites · 24.04.2026 · 16 (5) · 293

DOI: 10.3390/metabo16050293 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Metabolites, online erschienen am 24.04.2026. Verfasst von Ying Zhu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundamental Research Funds for the Central Universities, National Natural Science Foundation of China, CAMS Innovation Fund for Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Colorectal cancer (CRC) is a leading cause of cancer-related mortality, with colorectal liver metastasis (CRLM) being the major determinant of poor prognosis. Tumor metabolic reprogramming and spatial heterogeneity complicate biomarker discovery and clinical management. This study aimed to characterize the spatial metabolomic landscape of CRC and identify progression-associated metabolic alterations and potential metabolic signatures for liver metastasis.

Methods

A total of 23 tissue samples were collected from patients with CRC, with and without liver metastasis. Air flow-assisted desorption electrospray ionization mass spectrometry imaging (AFADESI-MSI) was used to map the spatial metabolite distributions. Region-of-interest analysis guided by histopathology enabled comparative metabolomic profiling across different tissue types. Multivariate statistical analysis, pathway enrichment, and receiver operating characteristic (ROC) curve analyses were performed to identify key metabolic alterations and evaluate potential biomarker performance.

Results

Distinct spatial metabolomic profiles were observed across normal mucosa, primary tumors, liver metastases, and normal liver tissues. In primary colorectal tumors, amino acid, purine, and choline metabolism were significantly upregulated, whereas liver metastases were characterized by elevated levels of triglycerides, diglycerides, cholesteryl esters, and acylcarnitines, indicating enhanced lipid synthesis, incomplete fatty acid oxidation, and/or mitochondrial dysfunction. Progression-associated analyses across tissue types revealed consistently increasing trends in glycerides and acylcarnitines, along with heterogeneous alterations in amino acids and phospholipids. Furthermore, 122 differential metabolites were identified between metastatic and non-metastatic CRC, and a four-lipid panel demonstrated strong discriminatory performance.

Conclusions

This study provides a spatially resolved characterization of metabolic reprogramming during CRC progression and liver metastasis, highlighting lipid and amino acid metabolism as key features and revealing the metabolic signatures of CRLM.

Schlagwörter

Stichwörter der Autor:innen

colorectal cancerliver metastasismass spectrometry imagingmetabolic landscapespatially resolved metabolomics

Autor:innen und Institutionen

  • Department of Laboratory Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China.
  • Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China.
  • State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China.

ORCID-Profile: Ying Zhu, Yixuan Cai

Förderung

  • Fundamental Research Funds for the Central Universities
  • National Natural Science Foundation of China
  • CAMS Innovation Fund for Medical Sciences
  • Noncommunicable Chronic Diseases-National Science and Technology Major Project
  • Fundamental Research Funds for the Central Universities, Peking Union Medical College
  • Noncommunicable Chronic Diseases—National Science and Technology Major Project

Zitieren

APA

Zhu, Y., Cai, Y., Wang, Q., Guo, H., Xie, Q., Xiang, Y., Yu, S., Wu, B., & Qiu, L. (2026). Spatially Resolved Metabolomic Profiling Reveals Progression-Associated Metabolic Reprogramming in Colorectal Liver Metastasis. Metabolites, 16(5), 293. https://doi.org/10.3390/metabo16050293

Vancouver

Zhu Y, Cai Y, Wang Q, Guo H, Xie Q, Xiang Y, et al. Spatially Resolved Metabolomic Profiling Reveals Progression-Associated Metabolic Reprogramming in Colorectal Liver Metastasis. Metabolites. 2026;16(5):293. doi:10.3390/metabo16050293

BibTeX
@article{Zhu2026,
  author = {Zhu, Ying and Cai, Yixuan and Wang, Qianyu and Guo, Hanchuan and Xie, Qianqian and Xiang, Yingshi and Yu, Songlin and Wu, Bin and Qiu, Ling},
  title = {Spatially Resolved Metabolomic Profiling Reveals Progression-Associated Metabolic Reprogramming in Colorectal Liver Metastasis},
  journal = {Metabolites},
  year = {2026},
  volume = {16},
  number = {5},
  pages = {293},
  doi = {10.3390/metabo16050293}
}
Kostenlos starten →